JAMP-URSODIOL: Dissolution is out of specification in affected lots
Last updated
Summary
Product
JAMP-URSODIOL
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Distribution
National
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| JAMP-URSODIOL | JAMP-URSODIOL | DIN 02472406 | Tablet | Ursodiol 500 mg | B20510B B20511BA |
Issue
Dissolution is out of specification in affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Jamp Pharma Corporation
1310 Nobel, Boucherville
Québec, J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Identification number
RA-74025
Get notified
Receive notifications for new and updated recalls and alerts by category.